Genitourinary tuberculosis accounts for approximately 5.3% of extrapulmonary [1]. It may involve the kidneys, ureters, bladder, prostate, vas deferens, epididymis, and testes. However, prostatic can exceptionally be found as an isolated lesion. We report a case 60-year-old patient who was admitted to emergency room with Acute urinary retention, treated benign hyperplasia, failure medical treatm...

Medical therapy for clinical benign prostatic hyperplasia (BPH) has advanced significantly in the last 2 decades. Many new α1 antagonists and 5α reductase inhibitors (5ARi) are now commercially available. The practicing urologist must decide on the most appropriate medication for his patients, taking into consideration various factors like efficacy, dosing regime, adverse effects, cost, patient...

PURPOSE To investigate the incidence of benign prostatic hyperplasia (BPH) in Korea and treatment patterns for 3 years after the diagnosis in a nationwide database. MATERIALS AND METHODS We created a cohort of patients diagnosed of BPH between 2007 and 2011 from the Health Insurance Review & Assessment database, a nationwide database of reimbursement. The diagnosis of BPH was defined as havin...

Benign prostatic hyperplasia and prostate cancer remain the most prevalent urologic health concerns affecting elderly men in their lifetime. Only 20% of benign prostatic hyperplasia and prostate cancer cases coexist in the same zone of the prostate and require a long time for initiation and progression. While the pathogenesis of both diseases is not fully understood, benign prostatic hyperplasi...

background and aims: prostate cancer is the second most common cancer in men worldwide in men. matrix metalloproteinase 2 (mmp2) has a role in the invasion and destruction of the basement membrane and the extra-cellular matrix and facilitating the process of tumor cell invasion. the present study was conducted to compare the expression of mmp2 gene in prostate cancer (pca) and benign prostatic ...

PURPOSE We conducted a safety and efficacy evaluation of intraprostatic injection of PRX302, a modified pore forming protein (proaerolysin) activated by prostate specific antigen, as a highly targeted, localized approach to treat lower urinary tract symptoms due to benign prostatic hyperplasia. MATERIALS AND METHODS A total of 92 patients with I-PSS (International Prostate Symptom Score) 15 o...

Background: Autopsy study is used to disclose many hidden prostatic pathologies and their incidence. Thecurrent aims evaluate the histopathological pattern of lesions such as nodular hyperplasia ofthe prostate, precancerous lesions, latent cancer in autopsy series males over age 50 correlatethem with age.Methods: The present was a prospective carried out pathology department, afteren bloc harve...

Annotation. The article presents a review of the literature on evolution hemostasis methods during open transbladder prostatectomy in patients with benign hyperplasia. improvement has gone from suturing prostate lodge, bladder neck and capsule to partial lodge installation Foley catheter for purpose mechanical compression lodge. Ukrainian urologists, including those Vinnytsia, are highlighted. ...